Oxycodone/Naloxone Ratiopharm (Oxycodone Hydrochloride, Naloxone Hydrochloride Dihydrate)

Oxycodone Hydrochloride, the active ingredient in Oxycodone/Naloxone Ratiopharm, is an opioid analgesic presented as a tablet for oral use. It is used to manage moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxycodone/Naloxone Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxycodone/Naloxone Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone/Naloxone combines a potent opioid agonist with an opioid antagonist to provide analgesia while reducing opioid‑induced constipation.

- Chronic cancer pain: improves pain control in patients with persistent malignant pain. - Post‑operative pain: provides short‑term relief after major surgery. - Severe non‑cancer chronic pain: offers analgesia when weaker opioids are ineffective. - Opioid‑induced bowel dysfunction: mitigates constipation associated with chronic opioid therapy. - Palliative care: supports comfort in end‑of‑life situations.

Oxycodone/Naloxone may produce a range of adverse reactions, most of which are dose‑dependent and related to its opioid activity.

Common Side Effects: - Nausea and vomiting - Constipation (less frequent than with oxycodone alone) - Dizziness - Drowsiness - Dry mouth - Headache

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Acute adrenal dysfunction - Allergic reactions such as rash or anaphylaxis - Opioid dependence or withdrawal syndrome - QT‑interval prolongation in susceptible patients

When prescribing Oxycodone/Naloxone, clinicians should consider several safety aspects.

- Assess patient history: evaluate risk factors for respiratory depression and opioid misuse. - Monitor renal and hepatic function: dose adjustments may be required in impairment. - Avoid concurrent CNS depressants: increased sedation risk. - Educate on constipation management: despite naloxone, bowel regimen may be needed. - Pregnancy: classify "." - Store at below 25°C: keep in the original pack and protect from moisture.

Oxyc​od ​​  

g   t ... ... ... ... ... ... ... ... ... ...  \